Cargando…

Peroxisomal Fitness: A Potential Protective Mechanism of Fenofibrate against High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has been increasing in association with the epidemic of obesity and diabetes. Peroxisomes are single membrane-enclosed organelles that play a role in the metabolism of lipid and reactive oxygen species. The present study examined the role of pero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Songling, Uddin, Md Jamal, Yu, Xiaoying, Piao, Lingjuan, Dorotea, Debra, Oh, Goo Taeg, Ha, Hunjoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723204/ https://www.ncbi.nlm.nih.gov/pubmed/35746892 http://dx.doi.org/10.4093/dmj.2021.0274

Ejemplares similares

Fyn Kinase: A Potential Therapeutic Target in Acute Kidney Injury
por: Uddin, Md Jamal, et al.
Publicado: (2020)

Associations of Circulating Irisin with FNDC5 Expression in Fat and Muscle in Type 1 and Type 2 Diabetic Mice
por: Jiang, Songling, et al.
Publicado: (2021)

TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease
por: Lee, Seon Myeong, et al.
Publicado: (2017)

Endogenous catalase delays high-fat diet-induced liver injury in mice
por: Piao, Lingjuan, et al.
Publicado: (2017)

Novel Role of Endogenous Catalase in Macrophage Polarization in Adipose Tissue
por: Park, Ye Seul, et al.
Publicado: (2016)

Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways
por: Dorotea, Debra, et al.
Publicado: (2020)

A novel pan-Nox inhibitor, APX-115, protects kidney injury in streptozotocin-induced diabetic mice: possible role of peroxisomal and mitochondrial biogenesis
por: Kwon, Guideock, et al.
Publicado: (2017)

Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stress
por: Dorotea, Debra, et al.
Publicado: (2022)

Integrative Omics Reveals Metabolic and Transcriptomic Alteration of Nonalcoholic Fatty Liver Disease in Catalase Knockout Mice
por: Na, Jinhyuk, et al.
Publicado: (2019)

Carbon monoxide releasing molecule-2 protects mice against acute kidney injury through inhibition of ER stress
por: Uddin, Md Jamal, et al.
Publicado: (2018)

Inhibition of Src Family Kinases Ameliorates LPS-Induced Acute Kidney Injury and Mitochondrial Dysfunction in Mice
por: Pak, Eun Seon, et al.
Publicado: (2020)

Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate
por: Osada, Miho, et al.
Publicado: (2014)

Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling
por: Uddin, Md Jamal, et al.
Publicado: (2021)

CO-Releasing Molecule-2 Prevents Acute Kidney Injury through Suppression of ROS-Fyn-ER Stress Signaling in Mouse Model
por: Uddin, Md Jamal, et al.
Publicado: (2021)

Uridine Prevents Fenofibrate-Induced Fatty Liver
por: Le, Thuc T., et al.
Publicado: (2014)

A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy
por: Strain, Joe D, et al.
Publicado: (2010)

Peroxisome Proliferator–Activated Receptor-α Agonism With Fenofibrate Does Not Suppress Inflammatory Responses to Evoked Endotoxemia
por: Mulvey, Claire K., et al.
Publicado: (2012)

PGC‐1α, a potential therapeutic target against kidney aging
por: Lee, Gayoung, et al.
Publicado: (2019)

Knockdown of PEX16 Induces Autophagic Degradation of Peroxisomes
por: Wei, Xiaofan, et al.
Publicado: (2021)

Prospective Pharmacological Potential of Resveratrol in Delaying Kidney Aging
por: Uddin, Md Jamal, et al.
Publicado: (2021)

Kidney protective potential of lactoferrin: pharmacological insights and therapeutic advances
por: Zahan, Md. Sarwar, et al.
Publicado: (2022)

Protective Effects of Black Cumin (Nigella sativa) and Its Bioactive Constituent, Thymoquinone against Kidney Injury: An Aspect on Pharmacological Insights
por: Hannan, Md. Abdul, et al.
Publicado: (2021)

Catalase Deficiency Accelerates Diabetic Renal Injury Through Peroxisomal Dysfunction
por: Hwang, Inah, et al.
Publicado: (2012)

A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
por: Ling, Hua, et al.
Publicado: (2013)

Epigenetic Regulation of Peroxisome Proliferator-Activated Receptor Gamma Mediates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease
por: Hajri, Tahar, et al.
Publicado: (2021)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

Fenofibrate, a peroxisome proliferator-activated receptor α-agonist, blocks lipopolysaccharide-induced inflammatory pathways in mouse liver
por: Won, Tae Wan
Publicado: (2013)

Fenofibrate Improves Insulin Resistance and Hepatic Steatosis and Regulates the Let-7/SERCA2b Axis in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice
por: Zhang, Dan, et al.
Publicado: (2022)

Influence of Fenofibrate Treatment on Triacylglycerides, Diacylglycerides and Fatty Acids in Fructose Fed Rats
por: Kopf, Thomas, et al.
Publicado: (2014)

Target Deconvolution of Fenofibrate in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis
por: Mahmoudi, Ali, et al.
Publicado: (2021)

Pathway Compartmentalization in Peroxisome of Saccharomyces cerevisiae to Produce Versatile Medium Chain Fatty Alcohols
por: Sheng, Jiayuan, et al.
Publicado: (2016)

Peroxisomal metabolic coupling improves fatty alcohol production from sole methanol in yeast
por: Zhai, Xiaoxin, et al.
Publicado: (2023)

KF-1607, a Novel Pan Src Kinase Inhibitor, Attenuates Obstruction-Induced Tubulointerstitial Fibrosis in Mice
por: Dorotea, Debra, et al.
Publicado: (2021)

Fenofibrate decreases radiation sensitivity via peroxisome proliferator-activated receptor α-mediated superoxide dismutase induction in HeLa cells
por: Liu, Xianguang, et al.
Publicado: (2012)

Orally active, species-independent novel A(3) adenosine receptor antagonist protects against kidney injury in db/db mice
por: Dorotea, Debra, et al.
Publicado: (2018)

Inhibitory Effects of Chung Hun Wha Dam Tang (CHWDT) on High-Fat Diet-Induced Obesity via AMP-Activated Protein Kinase Activation
por: Uddin, Md. Jamal, et al.
Publicado: (2012)

A role of peroxisome proliferator‐activated receptor γ in non‐alcoholic fatty liver disease
por: Skat‐Rørdam, Josephine, et al.
Publicado: (2019)

Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N-methyltransferase
por: van der Veen, Jelske N., et al.
Publicado: (2017)

Chemoselective Reduction of Fenofibric Acid to Alcohol in the Presence of Ketone by Mixed Anhydride and Sodium Borohydride
por: Majethia, Greesha N., et al.
Publicado: (2022)

Therapeutic effect of fenofibrate for non-alcoholic steatohepatitis in mouse models is dependent on regime design
por: Wang, Xinxue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g2qjeiuma8v6n688m0st78ih7l